The Reserve Bank of India (RBI) is studying the proposal submitted by Lupin for increasing the Foreign Institutional Investors (FIIs) shareholding limit from 33% to 49%. The company has applied to RBI for its approval pursuant to the resolution passed at the last Annual General Meeting (AGM) for the same.
Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.